OSTN
OSTN (osteocrin) is a secreted hormone of the osteocrin family that regulates dendritic growth in the developing cerebral cortex in response to sensory experience. It is also linked to bone growth, and it probably acts through the natriuretic peptide receptor NPR3/NPR-C. Browse Assay Genie's current range of OSTN research reagents below, or read on for the biology behind the target.
OSTN is a hormone that regulates dendritic growth in the developing cerebral cortex in response to sensory experience. Its expression is induced in the brain after membrane depolarisation. Once produced, it inhibits dendritic branching in neurons of the developing cortex, so it links neuronal activity to the shaping of dendritic arbors.
The proposed mechanism involves natriuretic peptide receptor NPR3/NPR-C. OSTN probably binds this receptor and so prevents natriuretic peptides from binding to it. The result is an increase in cGMP production. This places OSTN within natriuretic peptide signalling, where it acts by competing for a clearance-type receptor rather than by a separate route described in the source data.
The OSTN gene encodes a secreted protein that belongs to the osteocrin family. Gene annotation describes it as enabling hormone activity and as being involved in both bone growth and negative regulation of dendrite extension. The name osteocrin reflects the bone connection, while the neuronal role is a more recently described function. Orthologues of the OSTN gene are present in mouse and rat (both Ostn), which allows the protein to be studied in rodent models of cortical development. Researchers working on OSTN may use an OSTN antibody, an OSTN ELISA kit or recombinant OSTN protein to examine its secretion and activity-dependent regulation.
OSTN regulates dendritic growth in the developing cerebral cortex in response to sensory experience.
OSTN inhibits dendritic branching in cortical neurons, making it relevant to the negative regulation of dendrite extension.
OSTN probably binds NPR3/NPR-C, blocking natriuretic peptide binding and increasing cGMP production.
OSTN is induced in the brain following membrane depolarisation, linking neuronal activity to its expression.
OSTN is a secreted hormone that regulates dendritic growth in the developing cerebral cortex in response to sensory experience. It is induced after membrane depolarisation and inhibits dendritic branching in cortical neurons. It probably acts by binding NPR3/NPR-C, which increases cGMP production.
OSTN probably binds natriuretic peptide receptor NPR3/NPR-C. This prevents natriuretic peptides from binding to the receptor, which leads to increased cGMP production. The source annotation describes this as the probable mechanism rather than a confirmed one.
Yes. Mouse and rat both have an orthologous gene named Ostn. The protein belongs to the osteocrin family, and gene annotation links it to bone growth and to negative regulation of dendrite extension. Check the datasheet of any product for its validated reactivity.
Natriuretic peptides, their receptors and other targets relevant to OSTN signalling and cortical development.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P61366; product specifications from Assay Genie datasheets.